Literature DB >> 7645225

Egg fluids and cells of the chorioallantoic membrane of embryonated chicken eggs can select different variants of influenza A (H3N2) viruses.

C T Hardy1, S A Young, R G Webster, C W Naeve, R J Owens.   

Abstract

Growth of influenza viruses in embryonated eggs frequently results in the selection of virus variants with amino acid changes near the receptor-binding pocket of the hemagglutinin molecule, yet the mechanism by which this third form of influenza variation occurs (the other two being antigenic drift and shift) has not been clearly defined. Because egg-mediated variation might affect influenza vaccine and surveillance programs, we have initiated studies to determine the site(s) of variant virus selection within the embryonated egg. In this report we show that both the cells of the chorioallantoic membrane (CAM) and the fluids from embryonated chicken eggs are capable of selecting variant influenza viruses, but that these variants are distinct at the molecular level depending on the conditions of virus propagation. Serial passage of viruses in cells of the chorioallantoic membrane selects one set of variants which possess specific amino acid changes near the receptor binding pocket of the hemagglutinin molecule characteristic of viruses grown in embryonated eggs. However, passage of the same viruses in mammalian tissue culture cells supplemented with egg fluids selects a separate set of hemagglutinin variants also characteristic of viruses grown in eggs, yet at different residues from those observed following passage in CAM. These results suggest that two separate mechanisms may exist in the embryonated egg that lead to the selection of variant influenza viruses: one at the cellular level and another at the extracellular level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7645225     DOI: 10.1006/viro.1995.1405

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Long term trends in the evolution of H(3) HA1 human influenza type A.

Authors:  W M Fitch; R M Bush; C A Bender; N J Cox
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

3.  A replication-incompetent PB2-knockout influenza A virus vaccine vector.

Authors:  Sylvia T Victor; Shinji Watanabe; Hiroaki Katsura; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

5.  Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity.

Authors:  Wenjie Peng; Robert P de Vries; Oliver C Grant; Andrew J Thompson; Ryan McBride; Buyankhishig Tsogtbaatar; Peter S Lee; Nahid Razi; Ian A Wilson; Robert J Woods; James C Paulson
Journal:  Cell Host Microbe       Date:  2016-12-22       Impact factor: 21.023

6.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs.

Authors:  James Stevens; Li-Mei Chen; Paul J Carney; Rebecca Garten; Angie Foust; Jianhua Le; Barbara A Pokorny; Ramanunninair Manojkumar; Jeanmarie Silverman; Rene Devis; Karen Rhea; Xiyan Xu; Doris J Bucher; James C Paulson; James Paulson; Nancy J Cox; Alexander Klimov; Ruben O Donis
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

8.  Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.

Authors:  Noriko Kishida; Seiichiro Fujisaki; Masaru Yokoyama; Hironori Sato; Reiko Saito; Hideyuki Ikematsu; Hong Xu; Emi Takashita; Masato Tashiro; Shinichi Takao; Takuya Yano; Tomoko Suga; Chiharu Kawakami; Miwako Yamamoto; Keiko Kajiyama; Hiroyuki Saito; Shin'ichi Shimada; Sumi Watanabe; Satomi Aoki; Katsuya Taira; Miyako Kon; Jih-Hui Lin; Takato Odagiri
Journal:  Clin Vaccine Immunol       Date:  2012-04-04

Review 9.  H5N1 receptor specificity as a factor in pandemic risk.

Authors:  James C Paulson; Robert P de Vries
Journal:  Virus Res       Date:  2013-04-22       Impact factor: 3.303

Review 10.  Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.

Authors:  Aseem Pandey; Neetu Singh; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Hum Vaccin       Date:  2010-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.